Ascend Laboratories LLC is recalling bottles of Cefixime Capsules 400 mg because they contain failed impurities or degradation products that do not meet specifications. The recall affects 4,104 bottles distributed nationwide. No remedy details are currently provided in the record. Read more at govinfonow.com/recall/35576-ascend-labs-recalls-cefixime-capsules-due-to-impurity-issues.
“Ascend Labs Recalls Cefixime Capsules Due to Impurity Issues.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/35576-ascend-labs-recalls-cefixime-capsules-due-to-impurity-issues. Based on FDA recall #D-0229-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0229-2022%22&limit=1).
The FDA announced on November 3, 2021, that Ascend Laboratories LLC voluntarily recalled Cefixime Capsules 400 mg due to failed impurities and degradation specifications. The recall affects 4,104 bottles distributed nationwide.
How to tell if you have it
Brand: Ascend Laboratories
Product: Cefixime Capsules 400 mg
NDC: 67877-584-50
Lot code: 20140282
Expiration date: December 2021
Quantity: 4,104 bottles
The hazard
The recall was issued because the Cefixime Capsules failed impurities and degradation specifications. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Ascend Laboratories, LLC has had 35 other recalls on record since November 2, 2016. Other recent recalls of similar products include Dabigatran Etexilate Capsules (July 16, 2026), Amlodipine/Olmesartan tablets (July 8, 2026), and Dabigatran etexilate capsules (June 30, 2026). Other recent recalls of similar products include Temozolomide 5mg Capsules (March 3, 2026), Fluocinolone Acetonide Solution (December 30, 2025), and Methohexital Sodium (June 24, 2026).
How to tell if you have this one
Check your bottle for NDC 67877-584-50 and Lot number 20140282 with an expiration date of December 2021. The product is manufactured by Alken Laboratories Ltd. in India and distributed by Ascend Laboratories LLC in Parsippany, NJ.
Brand
Ascend Laboratories
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Bottle
Verify if your Cefixime Capsules match NDC 67877-584-50 and Lot 20140282 expiring in Dec 2021.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine if you have the recalled product and what steps to take next.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0229-2022 (November 3, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0229-2022 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.